Research Archive — Page 78 of 139

The team studying the regulation of innate immune response includes (front row, from left) Yang Zhao, Antiana Richardson, (back row, from left) John Karijolich, PhD, Xiang Ye and William Dunker.
May 6, 2021

Study finds that regulatory protein prevents signaling that triggers cell death

A protein implicated in neurodegenerative diseases including amyotrophic lateral sclerosis prevents the activation of an innate immune response that leads to cell death, Vanderbilt researchers have discovered.

By Leigh MacMillan
Sagittal brain scan illustration with cerebral blood vessels overlaid and a bright red glow highlighting the central brain region.
May 4, 2021

New strategy to treat brain bleeding

Vasorelaxing peptides could offer a promising therapeutic strategy for reducing the neurological deficits caused by subarachnoid hemorrhage-induced cerebral blood vessel constriction.

By Leigh MacMillan
Blue healthcare technology graphic featuring a large white medical cross, glowing digital wave lines, binary digits, and smaller icons for a person, water droplet, capsule, medical kit, heart, and envelope.
May 3, 2021

Strength in numbers

Voluntary data sharing across a region’s health systems and ambulatory care practices is important for measuring and improving health care quality and safety, Vanderbilt researchers report.

By Paul Govern
Paper cutout figures in red, yellow, gray, brown, tan, and black holding hands in a circle on a white surface.
April 29, 2021

Genetic ancestry and hypertension risk

Racial disparities in hypertension risk are due in part to genetic differences between ancestries, Vanderbilt investigators find in a study of participants in the Million Veteran Program.

By Bill Snyder
A caregiver gently holds and examines an older adult’s hand and wrist.
April 29, 2021

A compound to counteract aging?

A compound that increases lifespan in yeast is offering clues to pharmacological approaches that might slow the aging process and improve health.

By Leigh MacMillan
Portrait of Aviv Regev, PhD, wearing glasses and a gray sweater, standing beside a whiteboard covered with handwritten notes and diagrams.
April 28, 2021

Regev receives Vanderbilt Prize in Biomedical Science

Aviv Regev, PhD, an internationally known computational biologist and executive vice president of Genentech Research and Early Development (gRED), is the recipient of the 2021 Vanderbilt Prize in Biomedical Science, officials at Vanderbilt University Medical Center announced this week.

By Bill Snyder